Press releases

  • Sunday, 13 April 2014

    Real-world patient survey data shows negative impact of nocturia

    Read press release
  • Friday, 04 April 2014

    MSD, Ferring Pharmaceuticals and the World Health Organization - Working Together to Prevent Excessive Bleeding in Women after Childbirth

    Read press release
  • Wednesday, 05 February 2014

    New paper indicates a potential fifty-percent reduction in cardiac events for prostate cancer patients with pre-existing cardiovascular disease when treated with FIRMAGON® (degarelix) compared to LHRH agonists

    Read press release
  • Friday, 01 November 2013

    Ferring Pharmaceuticals appoints Alex Chang Senior Vice President, Asia Pacific

    Read press release
Archive:

Helen Gallagher

Senior Director
Corporate Communications
Tel: +41 58 301 00 51

Patrick Gorman

Associate Director
Corporate Communications
Tel: +41 58 301 00 53

Corporate Communications

Ferring International Center S.A.
Ch. de la Vergognausaz 50
CH-1162 Saint-Prex
Switzerland
Tel: +41 58 301 00 00
Fax: +41 58 301 00 10
email

Headquarters

Ferring International Center S.A.
Ch. de la Vergognausaz 50
1162 Saint-Prex
Switzerland

Tel:  +41 58 301 00 00
Fax: +41 58 301 00 10

Contact

GLOBAL LOCATOR